Serova, M., Tijeras-Raballand, A., Santos, C. D., Albuquerque, M., Paradis, V., Neuzillet, C., . . . de Gramont, A. (2015). Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients. Oncotarget.
Chicago Style CitationSerova, Maria, et al. "Effects of TGF-beta Signalling Inhibition With Galunisertib (LY2157299) in Hepatocellular Carcinoma Models and in Ex Vivo Whole Tumor Tissue Samples From Patients." Oncotarget 2015.
MLA CitationSerova, Maria, et al. "Effects of TGF-beta Signalling Inhibition With Galunisertib (LY2157299) in Hepatocellular Carcinoma Models and in Ex Vivo Whole Tumor Tissue Samples From Patients." Oncotarget 2015.
Warning: These citations may not always be 100% accurate.